Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Idiopathic hypereosinophilic syndrome with infiltration of cerebrospinal fluid by immature eosinophils: a case report and literature review.

Chou CW, Hsu SP, Chen MT, Chen MH, Shih YH, Lee LS, Lin CF.

Surg Neurol. 2007;68 Suppl 1:S52-5; discussion S55.

PMID:
17963925
3.

Efficacy of imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome and severe heart involvement.

Anghel G, De Rosa L, Ruscio C, Petti N, Riccardi M, Severino A, Majolino I.

Tumori. 2005 Jan-Feb;91(1):67-70. Review.

PMID:
15850007
4.
5.

Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate.

Coutré S, Gotlib J.

Semin Cancer Biol. 2004 Aug;14(4):307-15. Review.

PMID:
15305431
6.

[Clinical manifestations and treatment of chronic eosinophilic leukemia (CEL)/idiopathic hypereosinophilic syndrome (HES) in Japan].

Sada A, Matsui T.

Rinsho Ketsueki. 2010 Jul;51(7):515-25. Review. Japanese. No abstract available.

PMID:
20693771
7.

Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.

Hofmann SC, Technau K, Müller AM, Lübbert M, Bruckner-Tuderman L.

J Am Acad Dermatol. 2007 May;56(5 Suppl):S68-72. Review.

PMID:
17097375
8.

Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate.

Coutré S, Gotlib J.

Semin Cancer Biol. 2004 Feb;14(1):23-31. Review. Erratum in: Semin Cancer Biol. 2004 Aug;14(4):306. Corrected and republished in: Semin Cancer Biol. 2004 Aug;14(4):307-15.

PMID:
14757533
9.

FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.

Cools J.

Verh K Acad Geneeskd Belg. 2005;67(3):169-76. Review.

PMID:
16089297
10.

[Disorders with eosinophilia, treatment of hypereosinophilic syndrome].

Borbényi Z.

Orv Hetil. 2005 May 1;146(18 Suppl 1):911-6. Review. Hungarian.

PMID:
15921304
11.

Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders.

Pardanani A, Tefferi A.

Leuk Res. 2004 May;28 Suppl 1:S47-52. Review.

PMID:
15036941
12.

FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis.

Gilliland G, Cools J, Stover EH, Wlodarska I, Marynen P.

Hematol J. 2004;5 Suppl 3:S133-7. Review. No abstract available.

PMID:
15190295
13.

Imatinib mesylate for the treatment of hypereosinophilic syndromes.

Antoniu SA.

Curr Opin Investig Drugs. 2006 Nov;7(11):980-4. Review.

PMID:
17117585
14.

Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy--case report and literature review.

Baratta L, Afeltra A, Delfino M, De Castro S, Giorgino F, Rossi-Fanelli F.

Angiology. 2002 Jul-Aug;53(4):465-70. Review.

PMID:
12143954
15.

Management of hypereosinophilia in tropical settings.

Law AD, Varma SC.

Med J Armed Forces India. 2015 Jan;71(1):60-6. doi: 10.1016/j.mjafi.2014.11.008. Review.

Supplemental Content

Support Center